Cargando…

Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy

Detalles Bibliográficos
Autores principales: De Oliveira Santos, Júlia Gaspar, Rimoli, Caroline Fernandes, Sparaga, Lucas Demetrio, Dedavid, Vittoria Senna, Oyama, Letícia Akazaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582984/
http://dx.doi.org/10.1016/j.bjorl.2022.10.003
_version_ 1784812967007617024
author De Oliveira Santos, Júlia Gaspar
Rimoli, Caroline Fernandes
Sparaga, Lucas Demetrio
Dedavid, Vittoria Senna
Oyama, Letícia Akazaki
author_facet De Oliveira Santos, Júlia Gaspar
Rimoli, Caroline Fernandes
Sparaga, Lucas Demetrio
Dedavid, Vittoria Senna
Oyama, Letícia Akazaki
author_sort De Oliveira Santos, Júlia Gaspar
collection PubMed
description
format Online
Article
Text
id pubmed-9582984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Editora Ltda.
record_format MEDLINE/PubMed
spelling pubmed-95829842022-10-20 Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy De Oliveira Santos, Júlia Gaspar Rimoli, Caroline Fernandes Sparaga, Lucas Demetrio Dedavid, Vittoria Senna Oyama, Letícia Akazaki Braz J Otorhinolaryngol Article Published by Elsevier Editora Ltda. 2022 2022-10-20 /pmc/articles/PMC9582984/ http://dx.doi.org/10.1016/j.bjorl.2022.10.003 Text en Copyright © 2022 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
De Oliveira Santos, Júlia Gaspar
Rimoli, Caroline Fernandes
Sparaga, Lucas Demetrio
Dedavid, Vittoria Senna
Oyama, Letícia Akazaki
Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
title Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
title_full Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
title_fullStr Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
title_full_unstemmed Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
title_short Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
title_sort incidence and gravity of covid-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582984/
http://dx.doi.org/10.1016/j.bjorl.2022.10.003
work_keys_str_mv AT deoliveirasantosjuliagaspar incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy
AT rimolicarolinefernandes incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy
AT sparagalucasdemetrio incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy
AT dedavidvittoriasenna incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy
AT oyamaleticiaakazaki incidenceandgravityofcovid19inpatientswithallergicrhinitisundertreatmentwithsublingualimmunotherapy